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Introduction

Endoscopic Management

Discussion

Conclusion

While multiple causes exist for the development of
subglottic stenosis, the mechanism responsible for
idiopathic subglottic stenosis (ISS) remains unknown.
Proposed etiologies include gastro-esophageal reflux
(GERD) related exposure, telescoping of the first tracheal
ring under the cricoid cartilage, a hormonal cause, and
the possibility of an unidentified autoimmune process
(1,3,6,8,12,18,19).

Video bronchoscopy technique

The current study showed a rate of open procedures of 2
patients or 8%, at the low end of the range of 5% to 16%
in other similar studies. The rate of tracheostomy
dependence is also the lowest of the group along with
Giudice et al. at 0% (4,7,9,13,14,17,20).

ISS is a rare entity and this study adds to the available
reported experience. Favorable outcomes were seen
regarding symptom response, the number of endoscopic
procedures needed and as in other studies, patients were
encountered in this study that required only one
endoscopic procedure for symptom control at the time of
follow-up. Those who underwent an open procedure did
so after thirteen and fifteen endoscopic procedures, which
represent a much higher amount than the average of
approximately four endoscopic procedures in the
remaining population. The results obtained also showed
an auspicious outcome for all patients regarding
avoidance of a long-term tracheostomy tube with a low
incidence of tracheostomy placement, mainly at the
earlier stages of the study, and decannulation of all
patients. Additionally, ISS patients with circumferential
stenosis may still show success with endoscopic
management.

As ISS represents a rare disease of yet unknown etiology,
the optimal management remains to be defined. The
treatment options range from endoscopic management,
which is less invasive but tends to show recurrence to
open tracheal resection with anastomosis for those
patients in whom endoscopic techniques are ineffective or
have shown a high recurrence rate (5). Endoscopic
management is an outpatient procedure, which shows
limited voice alteration. In contrast, open resection
requires a hospital stay, can be associated with changes in
voice, and is reserved for centers with significant
expertise due to the demanding nature of the procedure
(11,15). However, the procedure results in complete
removal of the inflamed and stenotic area (2,10).
The available literature shows limited reports for
endoscopic management of ISS in more than twenty
patients. This study sought to add to the current literature
by reporting the experience at one institution, with a large
number of patients during a relatively condensed time
frame over which surgical technique has not varied.
Specific areas of evaluation in this work include the
presence of circumferential/cicatricial scarring which
previously has indicated that endoscopic management
would not be successful, as well as the goal for endoscopic
management as the sole technique rather than a
temporizing measure for open intervention. This study
also sought to identify any characteristics related to
interval of recurrence, which would help identify the
patient population in which endoscopic intervention
would be a favorable option.

Design
A retrospective chart review was completed to identify
possible patients. Attributes including age at diagnosis,
gender, smoking status and length of follow-up were
obtained. Reported GERD symptoms and details of any
medical management were acquired. A description of the
grade, location, length, type and histopathology of the
stenosis were attained where available. The number of
endoscopic procedures, steroid use (oral/injected),
Mitomycin C application and the longest interval between
procedures were recorded. An assessment of whether any
patient had undergone an open resection procedure
including laryngotracheoplasty or larygotracheal
resection was noted and if a tracheostomy had been
placed if the patient was subsequently decannulated. The
status of patient symptoms with regard to shortness of
breath, dyspnea, hoarseness and cough were obtained to
evaluate outcomes following intervention.

Under monitored anesthesia care, topical nasal
decongestant was applied, followed by topical anesthetic
application to the supraglottis, glottis and subglottis. A
video bronchoscope was introduced into the subglottis;
characteristics of the stenosis were documented and laser
safe precautions initiated. Laser radial incisions were
made in the stenosis followed by balloon dilation.
MDL with flexible bronchoscopy
Following intubation the laryngoscope was introduced
into the laryngea introitus and the patient was placed into
suspension. Intermittent apneic anesthesia was utilized to
allow intervention at the stenosis site. The video
bronchoscope was then inserted allowing introduction of
the laser for radial incision completion. Balloon dilation
was then achieved and re-intubation completed.
Pharmaceutical adjuncts
At the discretion of the surgeon either Mitomycin C or
Decadron were used in the following manner (16).
Mitomycin C (1 mg per mL soaked cottonoid pledgets
were placed over the area of intervention in the trachea.
The pledgets were left in place for 4 minutes and then
removed, after which cottonoid pledgets soaked in saline
were used to wipe the area clear. Injection of Decadron (4
mg/mL) was carried out with 0.3-0.5 mL injected at the
site.

Results
All patients in this study were female and the average age
at diagnosis was 50.84 years with a range of 31-73 years.
Tobacco use history indicated that 92% of patients never
smoked and 8% reported being former smokers with a
range of 5-10 pack years prior to cessation. Reflux
symptoms were noted in 24%. The average grade was
2.15 by the Cotton-Myer grading system, with a range of
1- 3. The stenosis was described as circumferential in
36%. The average number of endoscopic procedures was
4.08 with a range of 1 – 14 and 48% of the group under
went 2 or fewer. Twenty-eight percent received topical
Mitomycin C application and 12% underwent Decadron
injection; of the Mitomycin C group 12% underwent 2 or
fewer procedures. One patient each underwent
laryngotracheoplasty and laryngotracheal resection,
representing 8% of the group. Tracheostomy tubes were
placed at Jefferson in 16% and all were decannulated.
Average follow-up for the patients totaled 3.6 years
(1314.43 days) with a range of 0.2 – 10.22 years (72 –
3732 days).

Further comparison between the current study and the
pooled data of the previously performed studies shows a
similar average and range of age at diagnosis and percent
of patients with reflux symptoms at 24% vs. 29% was
noted. Patients in the current study showed an average
grade stenosis of 2.15 by Cotton-Myer and a range of 1-3.
The available literature showed wide variation in staging
systems used and reporting of grade of stenosis, thus
comparison data was not available. This study showed a
lower average number at 4.08 and range of 1 – 14
endoscopic procedures. While wide variation in the use
of intraoperative adjuncts in the outside studies made
comparison impossible, our study showed 28% use of
topical Mitomycin C and 12% use of Decadron injection.
The average time interval between procedures was 1.86
years (680 days) with a range of 0.05 – 8.07 years
(18-2,947 days). The average follow-up was
approximately 3.6 years and 8 months less in the current
study when compared to similar available literature
(4,7,9,13,14,17,20). Symptomatically 56% of patients
reported resolution of symptoms, 12% showed resolution
then recurrence, 28% showed improvement with residual
and 4% showed no change. No patients noted worsening
of symptoms or sustained complications as a result of the
endoscopic management employed.
The primary end point of the study was the longest
interval between procedures and the multivariate model
contains Mitomycin C application, circumferential
stenosis and the age at diagnosis. The model indicates
that if all other conditions are fixed, a patient given
Mitomycin C shows 4.39 times longer duration between
procedures. Certainly, a selection bias is possible in
surgeon selection of patients who would benefit from
application of this pharmacologic agent. Patients with
circumferential stenosis showed 1.84 times longer
duration between procedures. With regard to age, for
patients showing circumferential stenosis, every 1 year
increase in age at diagnosis would increase the longest
interval by 1.07 times. For patients without
circumferential stenosis, every 1-year increase in age at
diagnosis would decrease the longest interval to 93% of
the longest interval. During the follow-up period thus far
32% of patients underwent one procedure without
recurrence. Due to the rare nature of this disease process
and resulting low total number of patients included,
overall the model explains 52% of total variance.
As ISS is an uncommon entity, the power of this study
was not adequate to achieve statistically significant
results regarding the impact of grade or type of stenosis
on the number of endoscopic procedures, likelihood of
having a tracheostomy tube placed or if grade and
number of procedures was significant in symptomatic
resolution. Further research is needed and will be
completed based upon ongoing accrual.

With the positive results noted in this and prior studies in
mind and as endoscopic intervention shows lower
associated risks and is well tolerated, it is a rational
choice as the initial surgical management and may be
used in extended management for those who show
continued response and improvement.
.
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